Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Berks Center for ClinicalResearch
mi
from
Reading, PA
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Berks Center for ClinicalResearch
mi
from
Reading, PA
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Research Strategies of Memphis, LLC
mi
from
Memphis, TN
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Research Strategies of Memphis, LLC
mi
from
Memphis, TN
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research
mi
from
Austin, TX
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
FutureSearch Clinical Trials
mi
from
Austin, TX
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
FutureSearch Clinical Trials
mi
from
Austin, TX
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
FutureSearch Clinical Trials, LP
mi
from
Dallas, TX
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
FutureSearch Clinical Trials, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Bayou City Research, Ltd.
mi
from
Houston, TX
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Bayou City Research, Ltd.
mi
from
Houston, TX
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alliance Research Group
mi
from
Richmond, VA
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alliance Research Group
mi
from
Richmond, VA
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Research, Inc.
mi
from
Fort Lauderdale, FL
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Research, Inc.
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Centerpointe Hospital
mi
from
Saint Charles, MO
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Centerpointe Hospital
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
St. Louis Clinical Trials, LLC
mi
from
Saint Louis, MO
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
St. Louis Clinical Trials, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body Sensors
Remote Physiological, Behavioral and Symptom Assessment Study to Identify Predictors of Symptom Exacerbation and Relapse in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body Sensors
Remote Physiological, Behavioral and Symptom Assessment Study to Identify Predictors of Symptom Exacerbation and Relapse in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Novel Smoking Cessation Drug for Schizophrenia
The Development of of A Novel Therapeutic to Aid Tobacco Smoking Cessation in Persons With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  12/31/1969
Western Psychiatric Institute and Clinic and affilated sites
mi
from
Pittsburgh, PA
Novel Smoking Cessation Drug for Schizophrenia
The Development of of A Novel Therapeutic to Aid Tobacco Smoking Cessation in Persons With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 12/31/1969
Western Psychiatric Institute and Clinic and affilated sites
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism
A Randomized, Open Label, Parallel Group, Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism
A Randomized, Open Label, Parallel Group, Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Dyad Oxytocin Study (DOS)
Effects of Oxytocin on Familial Interactions
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Dyad Oxytocin Study (DOS)
Effects of Oxytocin on Familial Interactions
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Cerritos, CA
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Cerritos, CA
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Washington,
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Washington,
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Lauderhill, FL
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lauderhill, FL
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Leesburg, FL
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Leesburg, FL
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Maitland, FL
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Maitland, FL
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oakland Park, FL
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oakland Park, FL
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Tampa, FL
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Atlanta, GA
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Marlton, NJ
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Marlton, NJ
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Austin, TX
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Austin, TX
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity
Protocol 331-13-009: An Exploratory, Multicenter, Randomized, Double-Blind, fMRI Study of Fixed-dose Brexpiprazole (OPC-34712) (2 and 4 mg/Day Tablets) in Adults With Schizophrenia With Impulsivity
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine Medical Center
mi
from
Orange, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity
Protocol 331-13-009: An Exploratory, Multicenter, Randomized, Double-Blind, fMRI Study of Fixed-dose Brexpiprazole (OPC-34712) (2 and 4 mg/Day Tablets) in Adults With Schizophrenia With Impulsivity
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Treatment of Social Cognition in Schizophrenia Trial
TRuSST: Treatment of Social Cognition in Schizophrenia Trial
Status: Enrolling
Updated:  12/31/1969
Greater Los Angeles VA
mi
from
Los Angeles, CA
Treatment of Social Cognition in Schizophrenia Trial
TRuSST: Treatment of Social Cognition in Schizophrenia Trial
Status: Enrolling
Updated: 12/31/1969
Greater Los Angeles VA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Treatment of Social Cognition in Schizophrenia Trial
TRuSST: Treatment of Social Cognition in Schizophrenia Trial
Status: Enrolling
Updated:  12/31/1969
UCLA
mi
from
Los Angeles, CA
Treatment of Social Cognition in Schizophrenia Trial
TRuSST: Treatment of Social Cognition in Schizophrenia Trial
Status: Enrolling
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Treatment of Social Cognition in Schizophrenia Trial
TRuSST: Treatment of Social Cognition in Schizophrenia Trial
Status: Enrolling
Updated:  12/31/1969
Rush University
mi
from
Chicago, IL
Treatment of Social Cognition in Schizophrenia Trial
TRuSST: Treatment of Social Cognition in Schizophrenia Trial
Status: Enrolling
Updated: 12/31/1969
Rush University
mi
from
Chicago, IL
Click here to add this to my saved trials
Treatment of Social Cognition in Schizophrenia Trial
TRuSST: Treatment of Social Cognition in Schizophrenia Trial
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Treatment of Social Cognition in Schizophrenia Trial
TRuSST: Treatment of Social Cognition in Schizophrenia Trial
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
San Fernando Mental Health Center
mi
from
Granada Hills, CA
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
San Fernando Mental Health Center
mi
from
Granada Hills, CA
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Stanford School of Medicine
mi
from
Palo Alto, CA
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Stanford School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Henderson Behavioral Health
mi
from
Fort Lauderdale, FL
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Henderson Behavioral Health
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Meridian Behavioral Healthcare
mi
from
Gainesville, FL
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Meridian Behavioral Healthcare
mi
from
Gainesville, FL
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
U. of Florida College of Medicine
mi
from
Jacksonville, FL
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
U. of Florida College of Medicine
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
LifeStream Behavioral Center, Inc.
mi
from
Leesburg, FL
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
LifeStream Behavioral Center, Inc.
mi
from
Leesburg, FL
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Apalachee Center, Inc.
mi
from
Tallahassee, FL
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Apalachee Center, Inc.
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Jerome Golden Center for Behavioral Health
mi
from
West Palm Beach, FL
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Jerome Golden Center for Behavioral Health
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Grady Memorial Hospital
mi
from
Atlanta, GA
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Chestnut Health Systems
mi
from
Granite City, IL
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Chestnut Health Systems
mi
from
Granite City, IL
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of Iowa Psychiatry Research
mi
from
Iowa City, IA
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of Iowa Psychiatry Research
mi
from
Iowa City, IA
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Corrigan Mental Health Center
mi
from
Fall River, MA
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Corrigan Mental Health Center
mi
from
Fall River, MA
Click here to add this to my saved trials
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
U. Mass Medical School
mi
from
Worcester, MA
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
U. Mass Medical School
mi
from
Worcester, MA
Click here to add this to my saved trials